Homer1 regulates the susceptibility to TRAIL

Area of Science:

• Cell biology
• Molecular biology
• Biochemistry

Background:

• Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) induces programmed cell death.
• Understanding TRAIL sensitivity regulation is crucial for cancer therapy.
• TRAIL-resistant cells were generated to identify key regulatory factors.

Purpose of the Study:

• To identify regulatory proteins influencing sensitivity to TRAIL-induced apoptosis.
• To investigate the role of scaffolding protein Homer1 in TRAIL signaling.
• To elucidate the mechanism by which Homer1 affects apoptotic susceptibility.

Main Methods:

• Establishment of TRAIL-resistant HeLa (TR) cells through chronic TRAIL treatment.
• Western blot analysis to quantify Homer1 protein levels.
• Analysis of caspase-8 activation, Bid cleavage, and Bax translocation.
• Gene manipulation techniques including Homer1 reconstitution and shRNA-mediated knockdown.

Main Results:

• TRAIL-resistant cells exhibited significantly lower Homer1 protein levels compared to parental HeLa cells.
• These resistant cells showed delayed caspase-8 activation, Bid cleavage, and Bax translocation upon TRAIL stimulation.
• Reconstitution of Homer1 expression in TR cells restored TRAIL sensitivity.
• Knockdown of Homer1 in parental HeLa cells rendered them resistant to TRAIL.

Conclusions:

• Scaffolding protein Homer1 plays a critical role in determining cellular susceptibility to TRAIL-induced apoptosis.
• Homer1 levels directly correlate with the efficiency of TRAIL-mediated apoptotic signaling pathways.
• Targeting Homer1 may offer a strategy to modulate TRAIL sensitivity in therapeutic contexts.